|Articles|March 25, 2011

Medical Economics, Digital Edition, March 25th, 2011

Stay informed with the Medical Economics eNewsletter, delivering expert insights, financial strategies, practice management tips, and technology trends tailored for today’s physicians.

Latest CME

Video

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Jordan Axelrad, MD, MPH, FACG, FCCF; Jessica R. Allegretti, MD, MPH; Florian Rieder, MD

Medical Economics, Digital Edition, March 25th, 2011

Latest CME

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Trending on Medical Economics

Health care IT is drowning — and AI just made it worse

Sen. Roger Marshall's obstetrics practice sued more than 700 patients over unpaid bills

Trump says $500 checks will go to 1 million ACA enrollees starting in October

Americans still trust Fauci more than Kennedy on public health, even after a Senate panel held him in contempt

Virtual kidney-care companies show no consistent benefit despite billions in investment, PHTI finds